Diagnostics company bioMerieux (PARIS:BIM) has received 510(k) clearance from the U.S. Food and Drug Administration for a test to detect and screen for methicillin-resistant staphylococcus, more ...

An infectious disease test developer has raised $1.9 million in a series B financing round to advance its MRSA screening panel. It will also use the funds to develop its new molecular diagnostic ...

Polymerase chain reaction testing may be more clinically effective than chromogenic agar for MRSA screening, according to research published in BMC Infectious Diseases. For their study, researcher ...

Scientists have identified a new strain of MRSA that occurs both in human and dairy cow populations and could go undetected under standard MRSA testing, according to a University of Cambridge news ...

On Monday, the U.S. Food and Drug Administration approved a new test for methicillin-resistant Staphylococcus aureus detection manufactured by Cepheid. Cepheid’s Xpert MRSA NxG test delivers ...

bioMérieux, French manufacturer of diagnostic solutions, has received FDA 510(k) approval for NucliSENS EasyQ MRSA, an automated molecular test for MRSA, according to a company news release. The test ...

July 3, 2010 — A test to detect methicillin-resistant Staphylococcus aureus (MRSA) and S aureus (SA) has been recalled by the manufacturer based on an increasing number of complaints about false ...

The FDA has approved the first rapid blood test for methicillin-resistant Staphylococcus aureus (MRSA). It is the two-hour BD GeneOhm StaphSR Assay, which identified 100% of the MRSA-positive ...

MORRIS, ILLINOIS, USA, April 3, 2023/EINPresswire.com/ -- “MRSA and Staph aureus infections are the number one problem in U.S. healthcare facilities and greatly ...

Avoid unnecessary tests and antibiotics by applying evidence-based, cost-conscious infectious-disease decision-making, with ...